Boehringer Ingelheim Leads Collaborative Efforts in Essential Vaccination and Neutering Initiatives Towards a Rabies-Free Marinduque

Boehringer Ingelheim, in collaboration with the Global Alliance for Rabies Control (GARC), the Field Epidemiology Training Program Alumni Foundation, Inc. (FETPAFI), the municipal government of Marinduque and provincial veterinarians, spearheaded the Stop Rabies program to restore Marinduque’s rabies-free status. This collaborative effort focuses on increasing vaccination rates with a comprehensive campaign targeting dogs and cats across the province, while also promoting responsible pet ownership through mass spaying and castration. 

In photo: Representatives from Boehringer Ingelheim, the Global Alliance for Rabies Control (GARC), Field Epidemiology Training Program Alumni Foundation, Inc. (FETPAFI), municipal government officials, and provincial veterinarians collaborate on-site during the Stop Rabies vaccination and neutering campaign in Marinduque.

The Stop Rabies program supports the MiMaRoPa One Time, Big, an extension of the Marinduque Rabies Eradication Program, with the goal of making MiMaRoPa the first rabies-free region in the Philippines. These initiatives are part of Boehringer Ingelheim’s broader mission to enhance public health and animal welfare. To learn more about Stop Rabies and future initiatives, please visit https://www.boehringer-ingelheim.com/animal-health

Boehringer Ingelheim

Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing innovative therapies that can improve and extend lives in areas of high unmet medical need. Independent since its foundation in 1885, Boehringer takes a long-term perspective, embedding sustainability along the entire value chain. More than 53,500 employees serve over 130 markets to build a healthier, more sustainable, and equitable tomorrow.

 

Boehringer Ingelheim - Animal Health business  

Boehringer Ingelheim provides innovation for preventing and treating diseases in animals. The company offers a wide range of vaccines, parasite-control products, and medicines for pets, horses, and livestock to veterinarians, animal owners, farmers, and governments. As a leader in animal health, Boehringer Ingelheim values that the health of humans and animals is deeply connected and strives to make a difference for people, animals, and society.  

 

Learn more at www.boehringer-ingelheim.com.